Arcadia Biosciences (RKDA) Short Interest Ratio & Short Volume $5.01 -0.06 (-1.18%) As of 01/17/2025 03:56 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Arcadia Biosciences Short Interest DataArcadia Biosciences (RKDA) has a short interest of 43,600 shares, representing 3.21% of the float (the number of shares available for trading by the public). This marks a -62.45% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 43,760 shares to cover all short positions.Current Short Interest43,600 sharesPrevious Short Interest116,100 sharesChange Vs. Previous Month-62.45%Dollar Volume Sold Short$258,112.00Short Interest Ratio0.0 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares1,360,000 sharesFloat Size1,360,000 sharesShort Percent of Float3.21%Today's Trading Volume5,714 sharesAverage Trading Volume43,760 sharesToday's Volume Vs. Average13% Short Selling Arcadia Biosciences? Sign up to receive the latest short interest report for Arcadia Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRKDA Short Interest Over TimeRKDA Days to Cover Over TimeRKDA Percentage of Float Shorted Over Time Arcadia Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202443,600 shares $258,112.00 -62.5%3.2%0 $5.92 12/15/2024116,100 shares $731,430.00 +1,175.8%8.5%0.1 $6.30 11/30/20249,100 shares $25,389.00 -53.6%0.7%0 $2.79 11/15/202419,600 shares $56,840.00 -21.3%1.4%1.4 $2.90 10/31/202424,900 shares $96,114.00 +43.1%4.1%1.9 $3.86 10/15/202417,400 shares $49,068.00 -19.4%2.8%1.6 $2.82 Get the Latest News and Ratings for RKDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcadia Biosciences and its competitors with MarketBeat's FREE daily newsletter. 9/30/202421,600 shares $58,968.00 -17.2%3.5%2.7 $2.73 9/15/202426,100 shares $72,819.00 -13.3%4.3%3 $2.79 8/31/202430,100 shares $93,532.74 +1.4%4.9%3.5 $3.11 8/15/202429,700 shares $82,269.00 -29.8%4.9%2.9 $2.77 7/31/202442,300 shares $115,479.00 -24.5%7.1%1.8 $2.73 7/15/202456,000 shares $171,080.00 -1.4%9.3%2.4 $3.06 6/30/202456,800 shares $178,920.00 -9.4%9.5%2.2 $3.15 6/15/202462,700 shares $198,639.87 -13.3%10.4%2.3 $3.17 5/31/202472,300 shares $221,238.00 +1,264.2%12.0%2.4 $3.06 5/15/20245,300 shares $15,476.00 -50.5%0.9%0.2 $2.92 4/30/202410,700 shares $21,935.00 +161.0%1.8%0.5 $2.05 4/15/20244,100 shares $7,749.00 +10.8%0.7%0.2 $1.89 3/31/20243,700 shares $8,177.00 No Change0.6%0.2 $2.21 3/15/20243,700 shares $9,435.00 -9.8%0.6%0.1 $2.55 2/29/20244,100 shares $11,685.00 +51.9%0.7%0.1 $2.85 2/15/20242,700 shares $7,965.00 +80.0%0.5%0.1 $2.95 1/31/20241,500 shares $3,585.00 -91.0%0.3%0 $2.39 1/15/202416,600 shares $43,990.00 +97.6%2.8%0.5 $2.65 12/31/20238,400 shares $26,292.00 -19.2%1.4%0.2 $3.13 12/15/202310,400 shares $30,368.00 +82.5%1.7%0.5 $2.92 11/30/20235,700 shares $16,530.00 +18.8%1.0%0.3 $2.90 11/15/20234,800 shares $14,784.00 -52.9%0.8%0.3 $3.08 10/31/202310,200 shares $34,968.66 +100.0%1.7%0.6 $3.43 10/15/20235,100 shares $16,014.00 -8.9%0.9%0.3 $3.14 9/30/20235,600 shares $18,760.00 +33.3%0.9%0.2 $3.35 9/15/20234,200 shares $15,414.00 +600.0%0.7%0.1 $3.67 8/31/2023600 shares $2,100.00 -87.2%0.1%0 $3.50 8/15/20234,700 shares $20,539.00 -57.7%0.8%0.1 $4.37 7/31/202311,100 shares $49,062.00 -33.1%1.9%0.3 $4.42 7/15/202316,600 shares $74,036.00 +44.4%2.8%0.3 $4.46 6/30/202311,500 shares $44,620.00 +29.2%1.9%0.3 $3.88 6/15/20238,900 shares $37,024.00 -29.9%1.5%0.3 $4.16 5/31/202312,700 shares $58,293.00 +2.4%2.2%0.4 $4.59 5/15/202312,400 shares $61,008.00 -69.8%2.1%0.1 $4.92 4/30/202341,000 shares $250,100.00 -1.9%6.9%0.3 $6.10 4/15/202341,800 shares $278,806.00 +1.0%7.1%0.3 $6.67 3/31/202341,400 shares $309,258.00 -42.8%7.1%0.3 $7.47 3/15/202372,400 shares $528,520.00 +2,684.6%12.3%0.5 $7.30 2/28/20232,600 shares $650.26 -97.5%0.4%0 $0.25 2/15/2023102,700 shares $27,729.00 +13.5%N/A0.4 $0.27 1/31/202390,500 shares $23,502.85 -23.1%N/A0.4 $0.26 1/15/2023117,700 shares $42,360.23 +16.3%N/A0.6 $0.36 12/30/2022101,200 shares $27,425.20 -63.2%N/A0.5 $0.27 12/15/2022274,900 shares $87,913.02 -38.1%N/A1.5 $0.32 11/30/2022443,800 shares $148,761.76 -28.7%N/A2.4 $0.34 11/15/2022622,500 shares $208,288.50 +83.6%N/A3.1 $0.33 10/31/2022339,000 shares $142,719.00 -10.9%N/A1.7 $0.42 10/15/2022380,400 shares $154,594.56 -6.7%N/A2.3 $0.41 9/30/2022407,800 shares $215,277.62 -3.0%N/A2.7 $0.53 9/15/2022420,200 shares $322,713.60 -12.0%N/A2.7 $0.77 8/31/2022477,500 shares $416,618.75 -10.1%N/A2.9 $0.87 8/15/2022531,400 shares $526,086.00 +14.6%N/A2.9 $0.99 7/31/2022463,800 shares $388,664.40 -1.9%2.2%1.4 $0.84 7/15/2022472,700 shares $466,791.25 +13.3%2.3%1.3 $0.99 6/30/2022417,400 shares $417,400.00 -29.6%2.0%0.9 $1.00 6/15/2022592,900 shares $610,687.00 -16.8%2.8%0.7 $1.03 5/31/2022712,600 shares $976,262.00 +9.7%3.4%0.3 $1.37 5/15/2022649,600 shares $656,096.00 -14.6%3.1%0.3 $1.01 4/30/2022760,900 shares $734,268.50 -25.4%3.6%0.3 $0.97 4/15/20221,020,000 shares $1.09 million -19.1%4.9%0.5 $1.07 3/31/20221,260,000 shares $1.76 million -58.4%6.0%0.5 $1.40 3/15/20223,030,000 shares $4.51 million +311.7%14.4%1.3 $1.49 2/28/2022735,900 shares $732,220.50 -23.1%3.5%0.6 $1.00 2/15/2022956,900 shares $995,176.00 -8.0%4.6%1 $1.04 1/31/20221,040,000 shares $908,960.00 -9.6%5.1%1.1 $0.87 1/15/20221,150,000 shares $1.18 million +30.7%5.7%1.1 $1.03 12/31/2021880,100 shares $915,304.00 +8.8%4.3%1 $1.04 12/15/2021809,000 shares $809,000.00 -5.7%4.0%2.4 $1.00 11/30/2021857,700 shares $1.11 million -19.1%4.2%2.8 $1.29 11/15/20211,060,000 shares $2.18 million +6.9%5.2%3.4 $2.06 10/29/2021991,600 shares $1.93 million +11.1%4.9%3.3 $1.95 10/15/2021892,200 shares $1.81 million -8.2%4.4%3.6 $2.03 9/30/2021971,600 shares $2.01 million -30.1%4.8%3.3 $2.07 9/15/20211,390,000 shares $2.99 million -2.8%6.8%4.1 $2.15 8/31/20211,430,000 shares $3.46 million +7.5%7.1%2.9 $2.42 8/13/20211,330,000 shares $3.13 million +7.3%6.6%2.3 $2.35 7/30/20211,240,000 shares $2.91 million -4.6%6.4%2 $2.35 7/15/20211,300,000 shares $3.43 million +13.0%6.7%1.5 $2.64 6/30/20211,150,000 shares $3.42 million +13.9%5.9%1.3 $2.97 6/15/20211,010,000 shares $2.75 million -9.8%5.2%0.4 $2.72 5/28/20211,120,000 shares $3.17 million -15.8%5.7%0.5 $2.83 5/14/20211,330,000 shares $3.15 million -2.2%N/A0.6 $2.37 4/30/20211,360,000 shares $3.67 million -19.1%N/A0.4 $2.70 4/15/20211,680,000 shares $4.25 million +40.0%N/A0.6 $2.53 3/31/20211,200,000 shares $2.80 million +13.2%N/A0.4 $2.33 3/15/20211,060,000 shares $3.28 million +6.7%N/A0.6 $3.09 2/26/2021993,100 shares $3.16 million -64.9%N/A0.6 $3.18 2/12/20212,830,000 shares $12.99 million +44.4%N/A1.9 $4.59 1/29/20211,960,000 shares $5.64 million +851.9%N/A3.3 $2.88 1/15/2021205,900 shares $580,638.00 +35.6%N/A0.5 $2.82 12/31/2020151,900 shares $378,231.00 +56.9%N/A0.5 $2.49 12/15/202096,800 shares $294,272.00 +39.7%N/A0.4 $3.04 11/30/202069,300 shares $230,609.61 -65.4%N/A0.3 $3.33 11/15/2020200,300 shares $562,843.00 -44.5%N/A1 $2.81 10/30/2020361,000 shares $1.12 million -32.8%N/A1.8 $3.09 10/15/2020536,900 shares $1.82 million -1.6%N/A2.6 $3.39 9/30/2020545,600 shares $1.53 million +20.0%N/A2.4 $2.80 9/15/2020454,600 shares $1.39 million -6.1%N/A2.1 $3.06 8/31/2020483,900 shares $1.51 million +10.0%N/A2.3 $3.12 8/14/2020439,800 shares $1.45 million +3.6%N/A2 $3.30 7/31/2020424,400 shares $1.51 million +22.9%N/A1.8 $3.56 7/15/2020345,400 shares $1.27 million +17.2%N/A1.5 $3.67 6/30/2020294,800 shares $1.11 million +1.2%N/A1.3 $3.76 6/15/2020291,200 shares $1.12 million -8.8%N/A1.2 $3.85 5/29/2020319,200 shares $1.14 million -46.8%N/A1.6 $3.58 5/15/2020600,200 shares $2.40 million +19.0%N/A3.1 $4.00 4/30/2020504,400 shares $2.26 million +2.7%N/A3.1 $4.49 4/15/2020491,100 shares $1.53 million -11.8%N/A2.2 $3.12 3/31/2020557,000 shares $2.55 million +3.3%N/A2.4 $4.57 3/13/2020539,000 shares $1.70 million -11.7%N/A3 $3.16 2/28/2020610,100 shares $1.53 million -18.6%N/A2.4 $2.50 2/14/2020749,600 shares $2.55 million +14.1%N/A2.7 $3.40 1/31/2020657,000 shares $2.90 million -11.4%N/A1.9 $4.42 RKDA Short Interest - Frequently Asked Questions What is Arcadia Biosciences' current short interest? Short interest is the volume of Arcadia Biosciences shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 43,600 shares of RKDA short. 3.21% of Arcadia Biosciences' shares are currently sold short. Learn More on Arcadia Biosciences' current short interest. What is a good short interest percentage for Arcadia Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.21% of Arcadia Biosciences' floating shares are currently sold short. Is Arcadia Biosciences' short interest increasing or decreasing? Arcadia Biosciences saw a decrease in short interest in December. As of December 31st, there was short interest totaling 43,600 shares, a decrease of 62.4% from the previous total of 116,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Arcadia Biosciences' float size? Arcadia Biosciences currently has issued a total of 1,360,000 shares. Some of Arcadia Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Arcadia Biosciences currently has a public float of 1,360,000 shares. How does Arcadia Biosciences' short interest compare to its competitors? 3.21% of Arcadia Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Arcadia Biosciences: S&W Seed (0.86%), Origin Agritech Limited (0.75%), Nocera, Inc. (2.52%), Edible Garden AG Incorporated (13.81%), CEA Industries Inc. (1.44%), Inspire Veterinary Partners, Inc. (0.42%), Shineco, Inc. (12.69%), African Agriculture Holdings Inc. (0.64%), Corteva, Inc. (1.64%), BrightView Holdings, Inc. (7.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Arcadia Biosciences stock? Short selling RKDA is an investing strategy that aims to generate trading profit from Arcadia Biosciences as its price is falling. RKDA shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arcadia Biosciences? A short squeeze for Arcadia Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RKDA, which in turn drives the price of the stock up even further. How often is Arcadia Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RKDA, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies S&W Seed Short Interest Data Origin Agritech Short Interest Data Nocera Short Interest Data Edible Garden Short Interest Data CEA Industries Short Interest Data Inspire Veterinary Partners Short Interest Data Shineco Short Interest Data African Agriculture Short Interest Data African Agriculture Short Interest Data CEA Industries Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RKDA) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcadia Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcadia Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RKDA Stock Alerts